Secretagogue Responsiveness and Gene Expression Profiles Differ between Single- and Dual-Hormone-Secreting Acidophils

Autor: FR Boockfor, C Farish, RP Visconti, JL Barth, J Zhang, WS Argraves

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bda16036d4e84f71a6d3e440471ad00d
https://doi.org/10.1210/endo-meetings.2011.part2.p2.p1-405

Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis.

Autor: Liu G; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia.; School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.; Centenary Institute, Sydney, New South Wales, Australia., Cooley MA; Department of Oral Biology and Diagnostic Sciences, Augusta University, Augusta, Georgia, USA., Jarnicki AG; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia.; Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, Victoria, Australia., Borghuis T; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Department of Pathology and Medical Biology, Groningen, Netherlands., Nair PM; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia., Tjin G; Woolcock Institute of Medical Research, Discipline of Pharmacology, the University of Sydney, Sydney, New South Wales, Australia., Hsu AC; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia., Haw TJ; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia., Fricker M; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia., Harrison CL; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia., Jones B; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia., Hansbro NG; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia.; School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.; Centenary Institute, Sydney, New South Wales, Australia., Wark PA; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia., Horvat JC; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia., Argraves WS; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA., Oliver BG; School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.; Woolcock Institute of Medical Research, Discipline of Pharmacology, the University of Sydney, Sydney, New South Wales, Australia., Knight DA; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia., Burgess JK; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Department of Pathology and Medical Biology, Groningen, Netherlands.; Woolcock Institute of Medical Research, Discipline of Pharmacology, the University of Sydney, Sydney, New South Wales, Australia., Hansbro PM; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and the University of Newcastle, Newcastle, New South Wales, Australia.; School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.; Centenary Institute, Sydney, New South Wales, Australia.

Publikováno v: JCI insight [JCI Insight] 2019 Jul 25; Vol. 5. Date of Electronic Publication: 2019 Jul 25.

Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases.

Autor: Liu G; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Cooley MA; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA., Jarnicki AG; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Hsu AC; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Nair PM; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Haw TJ; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Fricker M; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Gellatly SL; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Kim RY; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Inman MD; Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Tjin G; Woolcock Institute of Medical Research, Discipline of Pharmacology, The University of Sydney, Sydney, New South Wales, Australia., Wark PA; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia., Walker MM; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Horvat JC; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia., Oliver BG; Woolcock Institute of Medical Research, Discipline of Pharmacology, The University of Sydney, Sydney, New South Wales, Australia; School of Life Sciences, The University of Technology, Sydney, New South Wales, Australia., Argraves WS; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA., Knight DA; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia; Department of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, British Columbia, Canada., Burgess JK; Woolcock Institute of Medical Research, Discipline of Pharmacology, The University of Sydney, Sydney, New South Wales, Australia; Discipline of Pharmacology, Sydney Medical School, The University of Sydney, New South Wales, Australia; Department of Pathology and Medical Biology, University of Groningen, University Medical Center, Groningen, Netherlands., Hansbro PM; Priority Research for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia.

Publikováno v: JCI insight [JCI Insight] 2016 Jun 16; Vol. 1 (9).

Total and isoform-specific quantitative assessment of circulating fibulin-1 using selected reaction monitoring MS and time-resolved immunofluorometry.

Autor: Overgaard M; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Cangemi C; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark., Jensen ML; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark., Argraves WS; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, USA., Rasmussen LM; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.; Centre for Individualized Medicine in Arterial Diseases, Odense University Hospital, Odense, Denmark.; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.

Publikováno v: Proteomics. Clinical applications [Proteomics Clin Appl] 2015 Aug; Vol. 9 (7-8), pp. 767-75. Date of Electronic Publication: 2015 Jan 12.

Fibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts.

Autor: Ge Q; 1] Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia [2] Discipline of Pharmacology, Sydney Medical School, The University of Sydney, NSW 2006, Australia., Chen L; Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia., Jaffar J; Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia., Argraves WS; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, USA., Twal WO; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, USA., Hansbro P; School of Biomedical Science and Pharmacy, The University of Newcastle, Callaghan, NSW 2308, Australia., Black JL; 1] Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia [2] Discipline of Pharmacology, Sydney Medical School, The University of Sydney, NSW 2006, Australia., Burgess JK; 1] Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia [2] Discipline of Pharmacology, Sydney Medical School, The University of Sydney, NSW 2006, Australia., Oliver B; 1] Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia [2] Discipline of Pharmacology, Sydney Medical School, The University of Sydney, NSW 2006, Australia [3] School of Medical &Molecular Biosciences, University of Technology Sydney, Sydney, NSW 2000, Australia.

Publikováno v: Scientific reports [Sci Rep] 2015 Apr 02; Vol. 5, pp. 9496. Date of Electronic Publication: 2015 Apr 02.